These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 33516065)
1. Honing the T cell response to HIV: Turning off the noise. Landau NR EBioMedicine; 2021 Feb; 64():103217. PubMed ID: 33516065 [No Abstract] [Full Text] [Related]
2. DC-based immunotherapy as strategy to purge the HIV reservoir? Søgaard OS EBioMedicine; 2019 May; 43():16-17. PubMed ID: 30981650 [No Abstract] [Full Text] [Related]
3. Poly(I:C) Potentiates T Cell Immunity to a Dendritic Cell Targeted HIV-Multiepitope Vaccine. Apostólico JS; Lunardelli VAS; Yamamoto MM; Cunha-Neto E; Boscardin SB; Rosa DS Front Immunol; 2019; 10():843. PubMed ID: 31105693 [TBL] [Abstract][Full Text] [Related]
4. Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA. Subramanya S; Armant M; Salkowitz JR; Nyakeriga AM; Haridas V; Hasan M; Bansal A; Goepfert PA; Wynn KK; Ladell K; Price DA; N M; Kan-Mitchell J; Shankar P Mol Ther; 2010 Nov; 18(11):2028-37. PubMed ID: 20648001 [TBL] [Abstract][Full Text] [Related]
5. Dancing with an escape artist. Deweerdt S Nature; 2010 Jul; 466(7304):S6-7. PubMed ID: 20631705 [No Abstract] [Full Text] [Related]
11. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever? Egan MA Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741 [No Abstract] [Full Text] [Related]
12. Measuring HIV-1-specific T cell immunity: how valid are current assays? D'Souza MP; Altfeld M J Infect Dis; 2008 Feb; 197(3):337-9. PubMed ID: 18184092 [No Abstract] [Full Text] [Related]
13. Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals. Thiébaut R; Hejblum BP; Hocini H; Bonnabau H; Skinner J; Montes M; Lacabaratz C; Richert L; Palucka K; Banchereau J; Lévy Y Front Immunol; 2019; 10():874. PubMed ID: 31105698 [TBL] [Abstract][Full Text] [Related]
14. Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses. Climent N; García I; Marradi M; Chiodo F; Miralles L; Maleno MJ; Gatell JM; García F; Penadés S; Plana M Nanomedicine; 2018 Feb; 14(2):339-351. PubMed ID: 29157976 [TBL] [Abstract][Full Text] [Related]
15. Characterization of an effective CTL response against HIV and SIV infections. Genescà M J Biomed Biotechnol; 2011; 2011():103924. PubMed ID: 21976964 [TBL] [Abstract][Full Text] [Related]
16. HIV vaccines: Unmasking myeloid derived suppressor cells. Green WR; O'Connor MA EBioMedicine; 2020 Nov; 61():103063. PubMed ID: 33038766 [No Abstract] [Full Text] [Related]
17. A therapeutic dendritic cell-based vaccine for HIV-1 infection. García F; Climent N; Assoumou L; Gil C; González N; Alcamí J; León A; Romeu J; Dalmau J; Martínez-Picado J; Lifson J; Autran B; Costagliola D; Clotet B; Gatell JM; Plana M; Gallart T; J Infect Dis; 2011 Feb; 203(4):473-8. PubMed ID: 21233310 [TBL] [Abstract][Full Text] [Related]
18. HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells. Wee EG; Ondondo B; Berglund P; Archer J; McMichael AJ; Baltimore D; Ter Meulen JH; Hanke T Mol Ther; 2017 Feb; 25(2):494-503. PubMed ID: 28153096 [TBL] [Abstract][Full Text] [Related]
19. Protection from HIV infection or AIDS? Miedema F; Meyaard L; Klein MR Science; 1993 Nov; 262(5136):1074-6. PubMed ID: 8235627 [No Abstract] [Full Text] [Related]
20. [FOXO1 transcription factor: a key player in T cell/HIV-1 interaction]. Roux A; Bismuth G; Mangeney M Med Sci (Paris); 2020 Jan; 36(1):24-26. PubMed ID: 32014093 [No Abstract] [Full Text] [Related] [Next] [New Search]